D-1056-2017 Class II Terminated
FDA drug recall D-1056-2017 was initiated by Teva Pharmaceuticals USA on July 24, 2017 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification; out of specification for tablet weight The recall status is terminated (terminated January 31, 2018). Affected quantity: 28,188 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- August 9, 2017
- Initiation Date
- July 24, 2017
- Termination Date
- January 31, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 28,188 bottles
Product Description
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60
Reason for Recall
Failed Tablet/Capsule Specification; out of specification for tablet weight
Distribution Pattern
Nationwide
Code Information
Lot # 3429066, exp 06/2018